A global COVID-19 knowledge-sharing platform has secured three new licensing agreements to transfer vaccine technologies, including one with the first private manufacturer to join the initiative, the World Health Organization ...
Aug 29, 2023
0
1
The Biden administration on Tuesday named the first 10 medicines that will be subject to price negotiations between Medicare and participating drug companies.
Aug 29, 2023
0
1
Plastics—in particular, microplastics—are among the most pervasive pollutants on the planet, finding their way into the air, water systems and food chains around the world. While the prevalence of microplastics in the ...
Aug 28, 2023
1
80
A new fund to fast-track patient access to potentially valuable new medicines may incentivize the pharmaceutical industry to develop high priced drugs for rare diseases with weak evidence on clinical benefits.
Aug 25, 2023
0
1
The U.S. Food and Drug Administration is approving more novel pharmaceutical drugs based on single clinical trials and with less public disclosure about those trials than was the norm just a few years ago, a pair of recent ...
Aug 24, 2023
1
99
For adults with moderate-to-severe atopic dermatitis (AD), dupilumab treatment yields significant improvement in sleep quality and other AD-related signs and symptoms, according to a study published online Aug. 10 in the ...
Aug 22, 2023
0
15
Patients report that a ketogenic diet (KD) improves multiple sclerosis (MS) symptoms, according to a study published in the August issue of Clinical Nutrition.
Aug 22, 2023
0
3
For patients with immunoglobulin A (IgA) nephropathy, nine months of treatment with targeted-release formulation of budesonide (Nefecon) yields a greater reduction in estimated glomerular filtration rate (eGFR) than placebo, ...
Aug 22, 2023
0
1
Tardive dyskinesia (TD) has a considerable impact on physical, psychological, social, and professional lives, according to a study published in the May/June issue of the Journal of Clinical Psychiatry.
Aug 22, 2023
0
2
For patients with venous thromboembolism (VTE) continuing warfarin or direct oral anticoagulants (DOACs) beyond six months, the risk for recurrent VTE is lower with DOACs, according to a study published online Aug. 15 in ...
Aug 21, 2023
0
0
